US 7998736
Adoptive immunotherapy with enhanced T lymphocyte survival
granted A61KA61K2039/55527A61K2239/57
Quick answer
US patent 7998736 (Adoptive immunotherapy with enhanced T lymphocyte survival) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/55527, A61K2239/57, A61K40/11, A61K40/35